Thrombocytopenia and platelet microvesicle formation caused by Legionella pneumophila infection.

[1]  John D Lambris,et al.  Compstatin Inhibits Complement and Cellular Activation in Whole Blood in Two Models of Extracorporeal Circulation , 1998 .

[2]  Breiman Rf,et al.  Legionnaires' disease : Clinical, epidemiological, and public health perspectives , 1998 .

[3]  A. Larsson,et al.  Increased platelet microvesicle formation is associated with mortality in a porcine model of endotoxemia , 1998, Acta anaesthesiologica Scandinavica.

[4]  T. Lindahl,et al.  Endotoxin induced platelet microvesicle formation measured by flow cytometry. , 1996, Platelets.

[5]  W. Johnson,et al.  Antibody-independent binding of complement component C1q by Legionella pneumophila , 1995, Infection and immunity.

[6]  J. Morera,et al.  Legionnaire's disease , 1994 .

[7]  L. Horstman,et al.  Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. , 1993, Thrombosis research.

[8]  T. Lindahl,et al.  C1q binding to platelets induced by monoclonal antibodies and immune complexes-a flow cytometric analysis. , 1993, Platelets.

[9]  J. Ramirez,et al.  Killing of Legionella pneumophila by nitric oxide in γ‐interferon‐activated macrophages , 1992 .

[10]  T. Lindahl,et al.  Studies of Fibrinogen Binding to Platelets by Flow Cytometry: An Improved Method for Studies of Platelet Activation , 1992, Thrombosis and Haemostasis.

[11]  W. Johnson,et al.  Legionella pneumophila lipopolysaccharide activates the classical complement pathway , 1992, Infection and immunity.

[12]  L. Horstman,et al.  Clinical significance of platelet microparticles in autoimmune thrombocytopenias. , 1992, The Journal of laboratory and clinical medicine.

[13]  P. Ward,et al.  Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury. , 1992, Journal of immunology.

[14]  M. Horwitz,et al.  Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of Legionella pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes , 1990, The Journal of experimental medicine.

[15]  C. Abrams,et al.  Direct detection of activated platelets and platelet-derived microparticles in humans. , 1990, Blood.

[16]  P. Sims,et al.  Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. , 1988, The Journal of biological chemistry.

[17]  S. Pfueller,et al.  Coagulation activities of plasma microparticles. , 1988, Thrombosis research.

[18]  M. Horwitz,et al.  Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors , 1987, The Journal of experimental medicine.

[19]  B. Nilsson,et al.  Simplified assays of hemolytic activity of the classical and alternative complement pathways. , 1984, Journal of immunological methods.

[20]  M. Horwitz.  Phagocytosis of the legionnaires' disease bacterium (legionella pneumophila) occurs by a novel mechanism: Engulfment within a Pseudopod coil , 1984, Cell.

[21]  R. Kekomäki,et al.  Interactions of immune complexes and platelets in rabbits immunized with hapten-carrier conjugates. , 2009, Acta pathologica et microbiologica Scandinavica. Section C, Immunology.

[22]  O. Mäkelä,et al.  Soluble antigen-antibody complexes and platelet aggregation. , 2009, Acta pathologica et microbiologica Scandinavica.